A Torre

No ORCID on file · 9 papers in corpus
guideline 2023
Management of women with abnormal uterine bleeding: Clinical practice guidelines of the French National College of Gynaecologists and Obstetricians (CNGOF)
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2023.07.001

OBJECTIVE: To provide French guidelines for the management of women with abnormal uterine bleeding (AUB). DESIGN: A consensus committee of 26 experts was formed. A formal conflict-of-interest policy was developed at the beginning of the pr…

guideline 2022
[French clinical practice guidelines developed by a modified Delphi consensus process for oocyte vitrification in women with benign gynecologic disease]
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2022.01.003

OBJECTIVES: To provide clinical practice guidelines about fertility preservation (FP) for women with benign gynecologic disease (BGD) developed by a modified Delphi consensus process for oocyte vitrification in women with benign gynecologic…

guideline 2022
[Management of women with abnormal uterine bleeding: Clinical practice guidelines of the French National College of Gynecologists and Obstetricians (CNGOF)]
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2022.02.078

OBJECTIVE: To provide French guidelines for the management of women with abnormal uterine bleeding (AUB). DESIGN: A consensus committee of 26 experts was formed. A formal conflict-of-interest (COI) policy was developed at the beginning of …

observational 2021
Efficacy of assisted reproductive technology after ovarian tissue transplantation in a cohort of 11 patients with or without associated infertility factors
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-020-02033-9

PURPOSE: IVF treatment in women with grafted frozen-thawed ovarian tissue is associated with poor reproductive outcomes. The aim of this study was to evaluate the efficacy of ovarian tissue transplantation (OTT) followed by assisted reprodu…

guideline 2018
[Epidemiology and diagnosis strategy: CNGOF-HAS Endometriosis Guidelines]
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2018.02.012

Based on the best evidence available, we have provided guidelines for clinical practice to target the nature of endometriosis as a disease, the consequences of its natural history on management, and the clinical and imaging evaluation of th…

guideline 2018
[Expectations of women with endometriosis: What information to deliver? CNGOF-HAS Endometriosis Guidelines]
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2018.02.005

Women with endometriosis often say that the information doctors give them should be improved. Patient support groups can provide missing information but may lack objectivity, or reliability, and may even generate anxiety or even harm their …

guideline 2018
Management of endometriosis: CNGOF/HAS clinical practice guidelines - Short version
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2018.06.003

First-line diagnostic investigations for endometriosis are physical examination and pelvic ultrasound. The second-line investigations are: targeted pelvic examination performed by an expert clinician, transvaginal ultrasound performed by an…

guideline 2018
[Management of endometriosis: CNGOF-HAS practice guidelines (short version)]
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2018.02.027

First-line investigations to diagnose endometriosis are clinical examination and pelvic ultrasound. Second-line investigations include pelvic examination performed by a referent clinician, transvaginal ultrasound performed by a referent ech…

review 2010
[Anatomic evaluation of the female of the infertile couple]
Journal de gynecologie, obstetrique et biologie de la reproduction ·doi:10.1016/S0368-2315(10)70029-6

One third of infertility cases are due to anatomical abnormalities of the female reproductive tract: endometrial polyps (33%), bilateral tubal blockage (12%), hydrosalpinx (7%), sub-mucosal fibroids (3%) and pelvic endometriosis. These may …